Skip to main content
Top
Published in: Reactions Weekly 1/2012

01-06-2012 | Case report

Gemcitabine

Haemolytic uraemic syndrome in an elderly patient: case report

Published in: Reactions Weekly | Issue 1/2012

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literature
1.
go back to reference Park YJ, Yang K-S, Jung H-S, Nam HC, Jung SH, Kim BG, Kim KY, Kim J-H, Kim Y-O, Yun Y-S.A case of hemolytic uremic syndrome in a lung cancer patient treated with gemcitabine. Tuberculosis and Respiratory Diseases 72: 207-211, No. 2, 29 Feb 2012. Available from: URL: http://dx.doi.org/10.4046/trd.2012.72.2.207 - South Korea Park YJ, Yang K-S, Jung H-S, Nam HC, Jung SH, Kim BG, Kim KY, Kim J-H, Kim Y-O, Yun Y-S.A case of hemolytic uremic syndrome in a lung cancer patient treated with gemcitabine. Tuberculosis and Respiratory Diseases 72: 207-211, No. 2, 29 Feb 2012. Available from: URL: http://​dx.​doi.​org/​10.​4046/​trd.​2012.​72.​2.​207 - South Korea
Metadata
Title
Gemcitabine
Haemolytic uraemic syndrome in an elderly patient: case report
Publication date
01-06-2012
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214060-00072

Other articles of this Issue 1/2012

Reactions Weekly 1/2012 Go to the issue

Case report

Antineoplastics

Case report

Clozapine

Case report

Cefepime